[1] ESNAOLA NF, MEYER JE, KARACHRISTOS A, et al.Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma[J]. Cancer, 2016, 122:1349. doi: 10.1002/cncr.29692
[2] PAVLIDIS ET, PAVLIDIS TE.Pathophysiological consequences of obstructive jaundice and perioperative management[J]. Hepatobiliary Pancreat Dis Int, 2018, 17(1):17. doi: 10.1016/j.hbpd.2018.01.008
[3] 中华医学会消化内镜分会ERCP学组, 中国医师协会消化医师分会胆胰学组, 国家消化系统疾病临床医学研究中心.中国ERCP指南(2018版)[J].中华消化内镜杂志, 2018, 35(11):777. doi: 10.3760/cma.j.issn.1007-5232.2018.11.001
[4] BRAY F, FERLAY J, SOERJOMATARAM I, et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394. doi: 10.3322/caac.21492
[5] 胡冰, 周岱云, 龚彪, 等.1215例次恶性胆管梗阻内镜治疗的体会[J].中华外科杂志, 2001, 39(3):195. doi: 10.3760/j:issn:0529-5815.2001.03.008
[6] DOWSETT JF, VAIRA D, HATFIELD AR, et al.Endoscopic biliary therapy using the combined percutaneous and endoscopic technique[J]. Gastroenterology, 1989, 96(4):1180. doi: 10.1016/0016-5085(89)91639-9
[7] IWANO H, RYOZAWA S, ISHIGAKI N, et al.Unilateral versus bilateral drainage using self-expandable metallic stent for unresectable hilar biliary obstruction[J]. Dig Endosc, 2011, 23(1):43. doi: 10.1111/j.1443-1661.2010.01036.x
[8] LEE TH, KIM TH, MOON JH, et al.Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures:a multicenter, prospective, randomized study[J]. Gastrointest Endosc, 2017, 86(5):817. doi: 10.1016/j.gie.2017.04.037
[9] RAJU RP, JAGANMOHAN SR, ROSS WA, et al.Optimum palliation of inoperable hilar cholangiocarcinoma:comparative assessment of the efficacy of plastic and self-expanding metal stents[J]. Dig Dis Sci, 2011, 56(5):1557. doi: 10.1007/s10620-010-1550-5
[10] MUKAI T, YASUDA I, NAKASHIMA M, et al.Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures:a randomized controlled trial[J]. J Hepatobiliary Pancreat Sci, 2013, 20(2):214. doi: 10.1007/s00534-012-0508-8
[11] CAO J, PENG C, DING X, et al.Risk factors for post-ERCP cholecystitis:a single-center retrospective study[J]. BMC Gastroenterol, 2018, 18(1):128. doi: 10.1186/s12876-018-0854-3
[12] YANG J, WANG J, ZHOU H, et al.Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma:a randomized trial[J]. Endoscopy, 2018, 50(8):751. doi: 10.1055/s-0043-124870